Search Results 3791-3800 of 17638 for syphilis
Mayo Clinic researchers have developed a new scoring tool that links Alzheimer's disease subtypes with age of onset and the rate of cognitive decline in ...
placebo with azacitidine (AZA) as background therapy in patients ≥ 18 years of age with newly diagnosed acute myeloid leukemia (AML), excluding acute ...
When thinking about men's health, many people tend to think about heart disease or ailments that that affect men as they age, such as an[...].
ROCHESTER, Minn. — A team of Mayo Clinic researchers has developed an artificial intelligence (AI) system that can detect surgical site infections (SSIs) with ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic researcher Fergus Couch, Ph.D., has spent his career studying inherited breast cancer and cancer genetics. Early on, he saw that many families lived ...
ROCHESTER, MN − The Interdisciplinary Health Sciences Institute (IHSI) at the University of Illinois Urbana-Champaign has been awarded an up to $33 million ...
During Thanksgiving, food often takes center stage at gatherings of friends and family. The focus is on turkey, pie and all the sides. But it[...].
Staff at the Alzheimer's Disease Research Center at Mayo Clinic Florida are reaching out to communities underrepresented in healthcare to attract more people to ...
The primary purpose of this study is to demonstrate that Dupilumab is superior to placebo in achieving sustained remission off oral corticosteroids (OCS) in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.